An Australian stem cell and regenerative medicine company

December 12, 2017

Cynata To Drive Investor Support in Japan

Cynata is pleased to inform investors that, following the engagement of Japan- based investor relations firm Finantec Co., Ltd. (as announced on the 9th of August 2017), a series of investor briefings will be conducted in Japan this week to further raise awareness among the Japanese investor community.

October 30, 2017

Cell and Gene Meeting on the Mesa 2017

Cynata’s MD and CEO, Dr Ross Macdonald, recently presented on Cynata at the "Cell and Gene Meeting on the Mesa 2017

October 02, 2017

Cynata profiled in a special feature on platform technologies in Drug Development & Delivery

Cynata’s unique Cymerus™ mesenchymal stem cell technology is profiled in a new article on platform technologies in the new issue of industry publication Drug Development & Delivery

Derisking & Transforming Drug Development

September 04, 2017

Cynata Presentation at the 2017 Rodman & Renshaw Investment Conference

Please view our presentation at the 19th Annual Rodman & Renshaw Global Investment Conference

July 21, 2017

CNBC Interview With Ross Macdonald

Ross Macdonald tells CNBC about how the company has progressed to a phase 1 clinical trial

Watch Interview